ReWalk Robotics Ltd (NASDAQ:RWLK) is scheduled to post its quarterly earnings results before the market opens on Thursday, November 2nd. Analysts expect ReWalk Robotics to post earnings of ($0.35) per share for the quarter.

ReWalk Robotics (NASDAQ:RWLK) last released its earnings results on Thursday, August 3rd. The medical device company reported ($0.29) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.35) by $0.06. The company had revenue of $2.01 million during the quarter, compared to the consensus estimate of $1.71 million. ReWalk Robotics had a negative return on equity of 528.26% and a negative net margin of 389.13%. ReWalk Robotics’s quarterly revenue was up 145.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.64) EPS. On average, analysts expect ReWalk Robotics to post $-1.30 EPS for the current fiscal year and $-1.36 EPS for the next fiscal year.

Shares of ReWalk Robotics Ltd (RWLK) opened at 1.35 on Wednesday. The company’s market cap is $29.36 million. ReWalk Robotics Ltd has a 52-week low of $1.10 and a 52-week high of $3.60. The company has a 50-day moving average price of $1.52 and a 200-day moving average price of $1.49.

COPYRIGHT VIOLATION NOTICE: “ReWalk Robotics Ltd (RWLK) to Release Earnings on Thursday” was originally published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are reading this article on another site, it was copied illegally and republished in violation of US and international copyright & trademark laws. The correct version of this article can be read at https://theolympiareport.com/2017/11/01/rewalk-robotics-ltd-rwlk-to-release-earnings-on-thursday.html.

Several equities research analysts have recently issued reports on RWLK shares. Zacks Investment Research lowered ReWalk Robotics from a “buy” rating to a “hold” rating in a research note on Wednesday, July 5th. Canaccord Genuity lowered their price objective on ReWalk Robotics from $4.00 to $3.00 and set a “buy” rating for the company in a research note on Friday, August 4th. Finally, Oppenheimer Holdings, Inc. set a $4.00 price objective on ReWalk Robotics and gave the company a “buy” rating in a research note on Friday, August 4th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and three have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $4.63.

About ReWalk Robotics

ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk once again. The Company offers ReWalk, which is an exoskeleton that uses its tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement.

Earnings History for ReWalk Robotics (NASDAQ:RWLK)

Receive News & Ratings for ReWalk Robotics Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReWalk Robotics Ltd and related companies with Analyst Ratings Network's FREE daily email newsletter.